Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

RemSleep Holdings (RMSL) Research & Development (2022 - 2025)

RemSleep Holdings' Research & Development history spans 4 years, with the latest figure at $1500.0 for Q2 2025.

  • On a quarterly basis, Research & Development fell 98.86% to $1500.0 in Q2 2025 year-over-year; TTM through Sep 2025 was $9350.0, a 97.66% decrease, with the full-year FY2024 number at $187445.0, down 36.42% from a year prior.
  • Research & Development hit $1500.0 in Q2 2025 for RemSleep Holdings, down from $17200.0 in the prior quarter.
  • Over the last five years, Research & Development for RMSL hit a ceiling of $205220.0 in Q4 2023 and a floor of -$9350.0 in Q4 2024.
  • Historically, Research & Development has averaged $59727.5 across 4 years, with a median of $32416.5 in 2022.
  • The widest YoY moves for Research & Development: up 193.62% in 2024, down 104.56% in 2024.
  • Tracing RMSL's Research & Development over 4 years: stood at $152145.0 in 2022, then surged by 34.88% to $205220.0 in 2023, then plummeted by 104.56% to -$9350.0 in 2024, then surged by 116.04% to $1500.0 in 2025.
  • Business Quant data shows Research & Development for RMSL at $1500.0 in Q2 2025, $17200.0 in Q1 2025, and -$9350.0 in Q4 2024.